{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Endocrinology & Hormones > PsoralidinCAS：18642-23-4
Molecular Formula：C20H16O5
Molecular Weight：336.34
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：HPLC≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 18642-23-4 |
| Name | Psoralidin |
| Molecular Formula | C20H16O5 |
| Molecular Weight | 336.34 |
| Solubility | Soluble in DMSO |
| Purity | HPLC≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD10566617 |
| SMILES | O=C1C2=C(OC3=CC(O)=CC=C32)C4=CC(C/C=C(C)\C)=C(O)C=C4O1 |
| InChIKey | YABIJLLNNFURIJ-UHFFFAOYSA-N |
| InChI | InChI=1S/C20H16O5/c1-10(2)3-4-11-7-14-17(9-15(11)22)25-20(23)18-13-6-5-12(21)8-16(13)24-19(14)18/h3,5-9,21-22H,4H2,1-2H3 |
| PubChem CID | 5281806 |
| Target Point | Estrogen Receptor;Notch;COX;ROS;5-LOX |
| Passage | Stem Cells;Neuronal Signaling;Endocrinology & Hormones |
| Background | Psoralidin is an agonist of estrogen receptor (ER)α and ERβ; It is also a dual inhibitor of COX-2 and 5-LOX. Psoralidin significantly down-regulates NOTCH1 signaling. Psoralidin also greatly induced ROS production. |
| Unit | Bottle |
| Specification | 10mg 10mM*1mL in DMSO 50mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
